Mingxia Zhao Selected Research

Mingxia Zhao Research Topics

Disease

10	Neoplasms (Cancer) 02/2024 - 08/2011
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 03/2019
2	Inflammation (Inflammations) 01/2020 - 09/2016
2	Congenital Heart Defects (Congenital Heart Defect) 01/2020 - 11/2014
1	Infections 11/2023
1	Fibrosis (Cirrhosis) 10/2023
1	Disease Susceptibility (Diathesis) 01/2023
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Insulin Resistance 01/2020
1	Sleep Wake Disorders 01/2020
1	Heart Failure 01/2017
1	Ageusia (Hypogeusia) 02/2016
1	Postoperative Hemorrhage 11/2014
1	Hemorrhage 11/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2014
1	Brain Neoplasms (Brain Tumor) 08/2011

Drug/Important Bio-Agent (IBA)

3	pyrimidineIBA 08/2016 - 08/2011
2	SHP099IBA 01/2022 - 03/2019
2	angiotensin I (1-7)IBA 01/2017 - 09/2016
2	Mechlorethamine (Nitrogen Mustard)FDA Link 08/2016 - 09/2013
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2024
1	jasmonic acid (jasmonate)IBA 11/2023
1	ethyleneIBA 11/2023
1	Plant Growth Regulators (Plant Hormones)IBA 11/2023
1	Abscisic AcidIBA 11/2023
1	Indoleacetic Acids (Auxin)IBA 11/2023
1	GibberellinsIBA 11/2023
1	Nerve Growth Factors (Neurotrophins)IBA 10/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Transcription Activator-Like EffectorsIBA 01/2023
1	Human Serum Albumin FDA LinkGeneric 01/2020
1	Colloids (Colloid)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	LipidsIBA 01/2020
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 01/2020
1	CarbohydratesIBA 01/2020
1	VitaminsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	GlycogenIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Granzymes (Granzyme)IBA 03/2019
1	Tyrosine (L-Tyrosine)FDA Link 03/2019
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 03/2019
1	Complement System Proteins (Complement)IBA 03/2019
1	Gefitinib (Iressa)FDA Link 09/2017
1	Superoxides (Superoxide)IBA 09/2016
1	Angiotensin IIIBA 09/2016
1	7-Ala-angiotensin (1-7)IBA 09/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2016
1	Losartan (Cozaar)FDA LinkGeneric 09/2016
1	SolutionsIBA 11/2014
1	Heparin (Liquaemin)FDA LinkGeneric 11/2014
1	Fibrinogen (Factor I)FDA Link 11/2014
1	ErbB Receptors (EGF Receptor)IBA 04/2014
1	Sorafenib (BAY 43-9006)FDA Link 09/2013
1	QuinazolinesIBA 09/2013
1	(18F)fluoroethyltyrosineIBA 08/2011
1	compound 18IBA 08/2011

Therapy/Procedure

4	Immunotherapy 01/2022 - 02/2016
1	Therapeutics 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2014